Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2022 Dec 1;13:1105804. doi: 10.3389/fphar.2022.1105804

Corrigendum: Network pharmacology-based prediction of active compounds in Wenyang Jiedu Huayu formula acting on acute-on-chronic liver failure with experimental support in vitro and in vivo

Dan Tang 1,†, Ruo-Yu Wang 1,†, Ke-Wei Sun 1,*, Yunan Wu 1, Lin Ding 1, Yang Mo 2
PMCID: PMC9754151  PMID: 36532739

In the published article, there was an error in the Funding statement. The funding statement for the National Natural Science Foundation of China was displayed as “(8197152432 and 82104809).” The correct Funding statement appears below.

“Funding

This study was supported by the National Natural Science Foundation of China (81973833 and 82104809), and the Hunan University of Chinese Medicine Graduate student innovation topics (2020CX18).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES